Blue Trust’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Blue Trust's TXG Position: Q3 2026 in Review
Blue Trust opened a new position in 10x Genomics (TXG) in Q3 2026: 118 shares worth $10.7K. The stake represents ﹤0.01% of the portfolio and ranks #1689 among its holdings. This is a return to the name: Blue Trust previously reported a position in TXG as recently as Q3 2025.
Blue Trust first reported a position in TXG in Q3 2022 and has held it in 12 quarters since. The position peaked at $56.7K in Q2 2025. 411 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Blue Trust held 118 shares of 10x Genomics worth $10.7K as of Q3 2026.
- 10x Genomics was a new Blue Trust position in Q3 2026.
- 10x Genomics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1689 holding.
- Blue Trust first reported a position in 10x Genomics in Q3 2022 and has held it in 12 quarters since.
- Blue Trust's 10x Genomics position peaked at $56.7K in Q2 2025.
- 411 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.